Benzinga’s Top Pre-Market NASDAQ Losers (IMGN, OVTI, NOVL, ARMH)

ImmunoGen Inc
IMGN
dipped 23.12% to $6.45 in the pre-market session. IMGN has received a Refuse to File (RTF) letter from the FDA for its breast cancer treatment. OmniVision Technologies Inc
OVTI
lost 2.85% to $21.50 in the pre-market session. OVTI had reported weaker-than-expected Q1 revenue. Novell Inc
NOVL
fell 2.30% to $5.51 in the pre-market session. NOVL had posted weaker-than-expected FQ3 results. ARM Holdings Plc
ARMH
slipped 0.91% to $15.29 in pre-market trading. ARMH’s earnings are likely to fall by 8.26% this year. Read more
from Benzinga's Company news.
Loading...
Loading...
ARMH Logo
ARMHPrecidian ETFs Trust Arm Holdings PLC ADRhedged
$67.281.51%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
Not Available
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...